Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

US Patent 9896502 · Granted Feb 20, 2018

Estimated economic value: $256,960,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating refractory migraine2024
Conjugated biological molecules, pharmaceutical compositions and methods2024
Treating headache comprising administering an antibody to calcitonin gene-relate2023
Treating headache comprising administering an antibody to calcitonin gene-relate2023
Treating headache comprising administering an antibody to calcitonin gene-relate2023
Treating headache comprising administering an antibody to calcitonin gene-relate2023
Treating refractory migraine2021
Treating refractory migraine2021
Conjugated biological molecules, pharmaceutical compositions and methods2021
Antagonist antibodies directed against calcitonin gene-related peptide and metho2020
Antagonist antibodies directed against calcitonin gene-related peptide and metho2020
Antagonist antibodies directed against calcitonin gene-related peptide and metho2020